Login
$ARQT
$27.15 -$1.11 (3.93%) Live

Insider Transactions

What Arcutis Biotherapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 12 68
Total trades 23 110

Shares traded

3 months 12 months
Acquired 90,281 478,615
Disposed 110,629 513,096
Net activity −20,348 −34,481

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Matsuda Masaru EVP, Chief Legal Officer Nov 04 Open-market sale · S −40,000 $34.32 −$1.37M 111,289
Matsuda Masaru EVP, Chief Legal Officer Nov 04 Exercise / conversion · M +40,000 $3.64 +$146K 151,289
Matsuda Masaru EVP, Chief Legal Officer Nov 02 Open-market sale · S −1,219 $31.86 −$38.8K 111,289
Burnett Patrick EVP, Chief Medical Officer Nov 02 Open-market sale · S −943 $31.86 −$30K 116,649
Watanabe Todd See Remarks Nov 02 Open-market sale · S −4,377 $31.86 −$139K 712,826
Scott Robert A Director Oct 23 Grant / award · A +2,819 — — 2,819
Welgus Howard G. Director Oct 15 Open-market sale · S −4,728 $26.93 −$127K 35,207
Welgus Howard G. Director Oct 15 Exercise / conversion · M +2,254 $8.63 +$19.5K 39,935
Welgus Howard G. Director Oct 15 Exercise / conversion · M +1,018 $7.51 +$7.65K 37,681
Welgus Howard G. Director Oct 15 Exercise / conversion · M +822 $6.52 +$5.36K 36,663
Matsuda Masaru See Remarks Sep 16 Disclosed 10b5-1 sale · S −3,674 $25.00 −$91.9K 112,508
Welgus Howard G. Director Sep 15 Open-market sale · S −4,730 $24.18 −$114K 35,841
Welgus Howard G. Director Sep 15 Exercise / conversion · M +2,255 $8.63 +$19.5K 40,571
Welgus Howard G. Director Sep 15 Exercise / conversion · M +1,019 $7.51 +$7.65K 38,316
Welgus Howard G. Director Sep 15 Exercise / conversion · M +822 $6.52 +$5.36K 37,297
Matsuda Masaru See Remarks Sep 08 Disclosed 10b5-1 sale · S −9,989 $25.03 −$250K 116,182
Curran Terrie Director Aug 27 Open-market sale · S −27,052 $25.03 −$677K 23,526
Curran Terrie Director Aug 27 Exercise / conversion · M +27,052 $8.63 +$233K 50,578
Curran Terrie Director Aug 27 Open-market sale · S −11,148 $25.03 −$279K 23,526
Curran Terrie Director Aug 27 Exercise / conversion · M +11,148 $7.51 +$83.7K 34,674

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support